共 50 条
- [31] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66
- [33] Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (09): : 2378 - 2385
- [37] Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis American Journal of Clinical Dermatology, 2022, 23 : 747 - 747
- [39] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752